US investments in Egypt increase by 26%: Prime Minister Madbouly    Compact with Africa boosts G20 investments in the continent: Egypt's foreign minister    US officials knew of Ukraine's Trump anxiety    In Photos: 10th Int'l Theatre Without Fund Festival opens in Alexandria    51 brokerage companies granted licences to offer short-selling in Egypt's stock exchange    El Shams Housing to ink PPP deals with 4 contractors in Dec.    China is outspending the U.S. on 5G infrastructure, industry expert says    China makes unexpected short-term funding rate cut, the first since 2015    To prevent dementia, exercise is the answer – researchers say    Kuwait PM Jaber al-Mubarak declines reappointment as prime minister    Tennis: New Davis Cup format must be given chance to succeed, says Murray    Iran's Khamenei backs fuel price hike, blames ‘sabotage' for unrest    LIVE: Comoros v Egypt (2021 Africa Cup of Nations qualifiers)    Netherlands back where they belong: Van Dijk    European shares climb as U.S.-China trade talks dominate sentiment    Hong Kong protesters pinned back on campus, violence escalating    In Photos: Cairo Circus promises impressive shows this season    Bank workers in Lebanon to remain on strike on Monday: Union    Apple Watch detects irregular heartbeats in US study    Egypt's El-Badry promises performance will improve after Salah's return    Saudi Aramco to sell small stake on Riyadh exchange    Egypt to host the second trilateral meeting over GERD in December    The Jobs with the best and worst heart health according to Bupa study    Children are nearing slavery due to digital development: Al-Azhar grand imam    Bridging East and West: Egyptian musicians Abdallah Abozekry and Ali Baghdady in Paris concerts    Six people killed, 16 injured in fuel pipeline explosion in Behaira    Liverpool's forward Salah out of Egypt games with ankle problem    GERD: An ‘adaptive' agreement    10 tips to have your 30s starting a lifelong success    Nike to investigate its Oregon Project following Mary Cain's NYT op-ed    ‘Shining' sequel ‘Doctor Sleep' targets $25 mln opening, has Stephen King's blessing    Sisi: Egypt believes in comprehensive approach to human rights    Egypt rejects politicised reports on human rights conditions – parliament    Egypt to vote on 3-month extension of state of emergency Monday    Al Pacino says follows this mantra on every acting job    Remembering Mustafa Mahmoud, philosopher of his time    Court sentences six to death, 41 to lifetime imprisonment violence related case    Trump says he would release Mideast peace plan after Israeli elections    ACWA Power compares 3 bids to supply production units for Luxor power station    What do you know about gold alloying?    NBE announces EGP 2.5m prizes for handball youth teams for their world achievements    Jennifer Lopez evokes Egyptian outrage post her North Coast performance    Al-Sisi honours Egypt's scholars on Science Day    IS claims responsibility for suicide bombing killing 63 in Afghan wedding    Political parties gear up for parliamentary, senate, local elections    Unprecedented Glory: Egypt win Men's U-19 World Handball Championship    12th National Egyptian Theatre Festival fuel up public theatre art scene    Ministry of Environment has a plan for "black clouds season"    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.





WHO hails 'triumph' as Ebola vaccine gets European green light
Published in Ahram Online on 20 - 10 - 2019

The vaccine, developed by U.S. drugmaker Merck & Co, is already being used under emergency guidelines to try to protect people against the spread of a deadly Ebola outbreak in Democratic Republic of Congo.
It protects against the Zaire strain of the Ebola virus - the one that most commonly causes outbreaks.
The shot is also being reviewed under a fast-track system by regulators in the United States, with a decision expected in the first quarter of next year.
“This vaccine has already saved many lives in the current Ebola outbreak, and the decision by European regulators will help it to eventually save many more,” the WHO's director-general Tedros Adhanom Ghebreyesus said in a statement.
The Congo Ebola outbreak has killed more than 2,100 people since the middle of last year. It is the second-largest Ebola outbreak in history, after a 2013-16 epidemic in West Africa that killed more than 11,300.

The Merck vaccine, which the company has now brand-named Ervebo, is likely to get a full marketing license from the European Commission in a few weeks.
Roger Perlmutter, president of Merck Research Laboratories, said the company's priority now was to get regulatory approval of its Ervebo manufacturing site in Germany so that licensed supply of the vaccine “can be used to support global public health preparedness”.
Merck's vaccine is being used in Congo in a so-called “ring vaccination” approach, in which people who may have been in contact with someone newly infected with Ebola are traced and offered the shot to protect them.
Charlie Weller, head of vaccines at the Wellcome Trust global heath charity said the Merck shot had already saved “countless lives” in the country.
“Having this vaccine available under research conditions has been key in preventing the ongoing outbreak in the DRC spiraling into a repeat of the 2014-16 epidemic, where 11,000 people died,” she told Reuters.
Health authorities in Kinshasa said last week they planned to introduce an experimental second Ebola vaccine, developed by drugmaker Johnson & Johnson, in the country's eastern provinces in November.
The Ebola virus causes hemorrhagic fever and spreads from person to person through direct contact with body fluids. It kills around half of those it infects.
There are currently no licensed treatments for the deadly infection, but scientists said in August they were a step closer to being able to cure it after two experimental drugs showed survival rates of as much as 90% in a clinical trial in Congo.


Clic here to read the story from its source.